🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brandon Cieniewicz

ORCID: 0000-0003-3268-7444

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients”.

Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients

Science Translational Medicine(2021)10.1126/scitranslmed.abf5264

N/A

0.633DataRank · unranked

67 citations

Alma‐Martina Cepika, Rajni Agarwal‐Hashmi, Gopin Saini, Molly Javier Uyeda, David M. Louis +17 more

IKKalpha-Mediated Non-canonical NF-kappaB Signaling is Required to Support Murine Gammaherpesvirus 68 Latency In Vivo

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.05.475165

N/A

0.104DataRank · unranked

1 citations

Varvara Kirillov, Isabel Daher, Xiaofan Li, Darby G. Oldenburg, Qiwen Dong +4 more

BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation

Frontiers in Immunology(2021)10.3389/fimmu.2021.683680

N/A

0DataRank · unranked

24 citations

Robert A. Freeborn, Brandon Cieniewicz, Rosa Romano, Ping Chen, Jeffrey Liu +6 more

Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy

Cytotherapy(2021)10.1016/j.jcyt.2021.05.010

N/A

0DataRank · unranked

11 citations

Ping Chen, Molly Javier Uyeda, Brandon Cieniewicz, Ece Canan Sayitoğlu, Benjamin Thomas +5 more